Investigational Site Number :1560003

Chengdu 610072

2 studies enrolling now · 5 studies all time

What they study most

Allergic Fungal Rhinosinusitis, Amyotrophic Lateral Sclerosis, Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion, Kidney Transplant Rejection, Myasthenia Gravis

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease — Recruiting now
• A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation — Recruiting now
• Dupilumab in Allergic Fungal Rhinosinusitis (AFRS) (LIBERTY-AFRS-AI) — Completed
• Efficacy and Safety of Tolebrutinib (SAR442168) Tablets in Adult Participants With Generalized Myasthenia Gravis — Stopped early
• Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS) — Stopped early